These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 6896885)

  • 1. Microbicidal activity of peripheral blood monocytes from patients with Hodgkin's disease for Toxoplasma gondii.
    McLeod R; Estes RG
    J Infect Dis; 1982 Oct; 146(4):565. PubMed ID: 6896885
    [No Abstract]   [Full Text] [Related]  

  • 2. Plasma and leukocytic bactericidal activity in the course of chemotherapy of Hodgkin's disease.
    Wysocka J; Kemona H; Prokopowicz J; Kiluk S
    Acta Med Pol; 1987; 28(1-4):99-107. PubMed ID: 3506375
    [No Abstract]   [Full Text] [Related]  

  • 3. Bone mineral density, growth, and thyroid function in long-term survivors of pediatric Hodgkin's lymphoma treated with chemotherapy only.
    van Beek RD; van den Heuvel-Eibrink MM; Hakvoort-Cammel FG; van den Bos C; van der Pal HJ; Krenning EP; de Rijke YB; Pieters R; de Muinck Keizer-Schrama SM
    J Clin Endocrinol Metab; 2009 Jun; 94(6):1904-9. PubMed ID: 19293271
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of chemotherapy on the phagocytic activity of mononuclear cells in patients with Hodgkin's disease.
    Süss J; Bakács T; Molnár Z
    Allerg Immunol (Leipz); 1984; 30(4):251-4. PubMed ID: 6084424
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Can MOPP be replaced in the treatment of advanced Hodgkin's disease?
    Canellos GP
    Semin Oncol; 1990 Feb; 17(1 Suppl 2):2-6. PubMed ID: 1689509
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low risk of secondary leukemias after chemotherapy without mechlorethamine in childhood Hodgkin's disease. German-Austrian Pediatric Hodgkin's Disease Group.
    Schellong G; Riepenhausen M; Creutzig U; Ritter J; Harbott J; Mann G; Gadner H
    J Clin Oncol; 1997 Jun; 15(6):2247-53. PubMed ID: 9196137
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical features and treatment of Hodgkin's disease].
    Shirakawa S; Kita K; Kobayashi T; Ohno T
    Gan To Kagaku Ryoho; 1986 Mar; 13(3 Pt 1):421-34. PubMed ID: 3754108
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lung cancer after Hodgkin's disease: a nested case-control study of the relation to treatment.
    Swerdlow AJ; Schoemaker MJ; Allerton R; Horwich A; Barber JA; Cunningham D; Lister TA; Rohatiner AZ; Vaughan Hudson G; Williams MV; Linch DC
    J Clin Oncol; 2001 Mar; 19(6):1610-8. PubMed ID: 11250989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomized study for the treatment of advanced Hodgkin's disease: MOPP vs. LOPP.
    Avilés A; Díaz-Maqueo JC; García EL; Torras V; López-Vancell D
    Arch Invest Med (Mex); 1991; 22(1):45-50. PubMed ID: 1819976
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Doxorubicin, bleomycin, vinblastine, and dacarbazine (ABVD) salvage of mechlorethamine, vincristine, prednisone, and procarbazine (MOPP)-resistant advanced Hodgkin's disease.
    Piga A; Ambrosetti A; Todeschini G; Cetto G; Perona G; Cellerino R
    Cancer Treat Rep; 1984; 68(7-8):947-51. PubMed ID: 6204754
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Successful chemotherapy of cancer. Remission of Hodgkin's disease. IV].
    Lopez M
    Clin Ter; 2001; 152(3):203-6. PubMed ID: 11692542
    [No Abstract]   [Full Text] [Related]  

  • 12. Nitroblue tetrazolium test in patients with Hodgkin's disease in the course of chemotherapy.
    Kemona H; Wysocka J; Prokopowicz J; Kiluk S
    Neoplasma; 1987; 34(1):107-13. PubMed ID: 3561600
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Chemotherapy of patients with Hodgkin's disease].
    Onoshi T
    Nihon Naika Gakkai Zasshi; 1994 Jun; 83(6):912-6. PubMed ID: 7964042
    [No Abstract]   [Full Text] [Related]  

  • 14. Randomized study for the treatment of adult advanced Hodgkin's disease: mechlorethamine, vincristine, procarbazine, and prednisone (MOPP) versus lomustine, vinblastine, and prednisone.
    Liebman HA; Hum GJ; Sheehan WW; Ryden VM; Bateman JR
    Cancer Treat Rep; 1983 May; 67(5):413-9. PubMed ID: 6342771
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of early stages of Hodgkin's disease with novantrone, vincristine, vinblastine, prednisone, and radiotherapy.
    Hagemeister FB; Purugganan R; Fuller L; McLaughlin P; Swan F; Romaguera J; Rodriguez M; Cabanillas F
    Semin Hematol; 1994 Apr; 31(2 Suppl 3):36-43. PubMed ID: 8073308
    [No Abstract]   [Full Text] [Related]  

  • 16. [Recurrent paralysis induced by vincristine during the treatment of Hodgkin's disease].
    Chauffert B; Lorcerie B; André F; Besancenot JF; Martin F
    Presse Med; 1989 Nov; 18(39):1930-1. PubMed ID: 2531872
    [No Abstract]   [Full Text] [Related]  

  • 17. Treatment of childhood Hodgkin's disease.
    Ekert H
    J Clin Oncol; 1991 Mar; 9(3):528-9. PubMed ID: 1999723
    [No Abstract]   [Full Text] [Related]  

  • 18. Chemotherapy for Hodgkin's disease and aggressive non-Hodgkin's lymphoma. More is better, or is it?
    Dodwell DJ; de Campos ES; Radford JA
    Drugs; 1992 Jul; 44(1):1-8. PubMed ID: 1379906
    [No Abstract]   [Full Text] [Related]  

  • 19. [MOPP therapy of Hodgkin's disease previously treated with MOPP].
    Frau A; Montalar J
    Med Clin (Barc); 1985 May; 84(19):801. PubMed ID: 3839875
    [No Abstract]   [Full Text] [Related]  

  • 20. Combined-modality therapy for the treatment of Hodgkin's disease.
    Hoppe RT
    Front Radiat Ther Oncol; 1992; 26():172-80. PubMed ID: 1511919
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.